Antitumor activity of vaccines obtained from tumor cell membranes and Bac. mesentericus AB-56 metabolism products

Experimental Oncology

Volumn 20, Issue 2, 1998, Pages 143-146

  Potebnja, G P ^a   Semernikov, V A ^a   Lisovenko, G S ^a   Khutornoy, S V ^a   Tarasova, T A ^a  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

Immunotherapy; Tumor

Indexed keywords

EID: 0001711474     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rosenberg SA. Development of cancer immunotherapies based on identification on the genes encoding cancer regression antigens. J Natl Cancer Inst 1996; 88: 1635-44.
2. Correale P, Walmsley K, Nieroda E, Zaremba S, Lhu M, Schlom J, Tsang KY. In vitro generation of human cytotoxic T-lymphocytes specific for peptides derived from prostate-specific antigen. J Natl Cancer Inst 1997; 89: 293-300.
3. Fenton RG, Longo DL. Danger versus tolerance: paradigms for future studies of tumor-specific cytotoxic T lymphocytes. J Natl Cancer Inst 1997; 89: 272-5.
4. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.